During the past decade, UCSF Mount Zion Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSF Mount Zion Cancer Center" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCSF Mount Zion Cancer Center" are "Advanced Solid Tumor" (1 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Gastric Adenocarcinoma" (1 trials) and "Gynecologic Cancer" (1 trials). Many other conditions were trialed in "UCSF Mount Zion Cancer Center" in a lesser frequency.

Most popular intervention types in "UCSF Mount Zion Cancer Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Balixafortide" (1 trials), "Eribulin" (1 trials), "PY159 Single agent dose expansion cohort" (1 trials), "PY159 Single agent dose level 1" (1 trials) and "PY159 Single agent dose level 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSF Mount Zion Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCSF Mount Zion Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UCSF Mount Zion Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCSF Mount Zion Cancer Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".